Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

Suman Malempati; Douglas S. Hawkins

doi:10.1002/pbc.24118

Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

Suman Malempati, Douglas S. Hawkins

Research output: Contribution to journal › Review article › peer-review

309 Scopus citations

Abstract

The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

Original language	English (US)
Pages (from-to)	5-10
Number of pages	6
Journal	Pediatric Blood and Cancer
Volume	59
Issue number	1
DOIs	https://doi.org/10.1002/pbc.24118
State	Published - Jul 15 2012
Externally published	Yes

Keywords

Pediatric
Rhabdomyosarcoma
Soft-tissue sarcoma

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.24118

Cite this

@article{685ade51ef0142b488d17e3dacf9e4fc,

title = "Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies",

abstract = "The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.",

keywords = "Pediatric, Rhabdomyosarcoma, Soft-tissue sarcoma",

author = "Suman Malempati and Hawkins, {Douglas S.}",

year = "2012",

month = jul,

day = "15",

doi = "10.1002/pbc.24118",

language = "English (US)",

volume = "59",

pages = "5--10",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Rhabdomyosarcoma

T2 - Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

AU - Malempati, Suman

AU - Hawkins, Douglas S.

PY - 2012/7/15

Y1 - 2012/7/15

N2 - The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

AB - The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

KW - Pediatric

KW - Rhabdomyosarcoma

KW - Soft-tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84861214958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861214958&partnerID=8YFLogxK

U2 - 10.1002/pbc.24118

DO - 10.1002/pbc.24118

M3 - Review article

C2 - 22378628

AN - SCOPUS:84861214958

SN - 1545-5009

VL - 59

SP - 5

EP - 10

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 1

ER -

Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this